Profil

Tassin Alexandra

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Service de Physiologie et réadaptation respiratoire

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Physiologie et réadaptation respiratoire

Université de Mons - UMONS > Faculté de Médecine et de Pharmacie > Biochimie métabolique et moléculaire

ORCID
0000-0002-2154-7529
Main Referenced Co-authors
BELAYEW, Alexandra  (70)
COPPEE, Frédérique  (66)
LEGRAND, Alexandre  (61)
Ansseau, Eugénie  (43)
Laoudj-Chenivesse, Dalila (41)
Main Referenced Keywords
Homeodomain Proteins (3); Humans (3); Muscular Dystrophy, Facioscapulohumeral (3); Adiponectin (2); Cell Biology (2);
Main Referenced Unit & Research Centers
CREMH - Mind & Health (15)
UMHAP - Centre de Recherche UMONS-Ambroise Paré (3)
CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (1)
Main Referenced Disciplines
General & internal medicine (90)
Biotechnology (59)
Zoology (29)
Biochemistry, biophysics & molecular biology (24)
Cardiovascular & respiratory systems (6)

Publications (total 137)

The most downloaded
49 downloads
Decarnoncle, M., Decroo, C., Coppée, F., Tassin, A., Tagliatti, V., Villers, A., Colet, J.-M., Nonclercq, D., Legrand, A., Ris, L., Wattiez, R., & Decleves, A.-E. (25 November 2021). Développement d'une trousse de dosage d'organokines par spectrométrie de masse [Poster presentation]. Networking EpiCURA-UMONS, Baudour, Belgium. https://hdl.handle.net/20.500.12907/29838

The most cited

287 citations (Scopus®)

Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Chen, Y.-W. (01 November 2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104 (46), 18157-18162. doi:10.1073/pnas.0708659104 https://hdl.handle.net/20.500.12907/9738

Decarnoncle, M., Pierre, L., Francois, L., Marechal, L., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (05 April 2024). Impact of myokines on AMPK activity in chronic kidney disease induced by obesity [Paper presentation]. The meeting ERCSG 2024, Broxbourne, United Kingdom.

Nguyen, T. H., Limpens, M., Bouhmidi, S., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (15 March 2024). The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected. International Journal of Molecular Sciences, 25 (332). doi:10.20944/preprints202211.0532.v2
Peer Reviewed verified by ORBi

Nguyen, T.-H., Paprzycki, L., Legrand, A., Decleves, A.-E., Heher, P., Limpens, M., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (16 December 2023). Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene. Skeletal Muscle, 13 (1), 21. doi:10.1186/s13395-023-00330-2
Peer Reviewed verified by ORBi

Tassin, A. (2023). Un axe DUX4 HIF1 dans la FSHD ? Newsletter Amis FSH.

Decarnoncle, M., Marlier, H., Lhoir, F., Francois, L., Maréchal, L., Zwakhals, T., Juszczak, F., Decroo, C., Coppée, F., Tassin, A., Wattiez, R., & Decleves, A.-E. (01 December 2023). Organokine impact in obesity induced chronic kidney disease [Poster presentation]. GENDER DIFFERENCES IN RENAL DISEASE FOCUS ON DIABETES AND OBESITY, Garachico, Spain.

Paprzycki, L., Gourari, Y., Legrand, A., DEBACQ-CHAINIAUX, F., & Tassin, A. (24 November 2023). Effect of Episodic Hypoxaemia on skeletal muscle: which association with Ad pathway modifications? [Poster presentation]. PhyPhar Autumn Meeting.

Paprzycki, L., Gourari, Y., Legrand, A., Debacq-Chainiaux, F., & Tassin, A. (28 April 2023). Sustained Intermittent hypoxaemia as a component of COPD pathophysiology: which effect on skeletal muscle? [Paper presentation]. BELGIAN SOCIETY OF PHYSIOLOGY AND PHARMACOLOGY Spring Meeting 2023, Bruxelles, Belgium.
Editorial reviewed

Tassin, A., Mbolo ebubu, E. R., Vanpee, D., & Legrand, A. (2023). Développement d’un nouveau critère de jugement clinique pour la FSHD [Paper presentation]. FSHD time : Conférence de vulgarisation dédiée aux patients atteints de FSHD, La Louvière, Belgium.

Decarnoncle, M., Pierre, L., Francois, L., Maréchal, L., Zwakhals, T., Juszczak, F., Tassin, A., & Decleves, A.-E. (29 March 2023). Impact of myokines on AMPK activity in obesity-induced chronic kidney disease [Paper presentation]. Diabète de type 1 & Exercice physique : de la gestion des risques aux bénéfices pour la santé, Loos, France.

Claus, C., Slavin, M., Ansseau, E., Lancelot, C., Bah, K., Lassche, S., Fievet, M., Greco, A., Tomaiuolo, S., Tassin, A., Dudome, V., Kusters, B., Decleves, A.-E., Laoudj-Chenivesse, D., van Engelen, B. G. M., Nonclercq, D., Belayew, A., Kalisman, N., & Coppée, F. (07 March 2023). The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins. Skeletal Muscle, 13 (1), 5. doi:10.1186/s13395-022-00310-y
Peer Reviewed verified by ORBi

Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo [Paper presentation]. Physphar Spring meeting (2023), Brussels, Belgium.
Editorial reviewed

Szczepanski, S., Limpens, M., Decleves, A.-E., Legrand, A., & Tassin, A. (12 September 2022). Adiponectin pathway in a murine model of disuse muscle atrophy: in in vivo study [Poster presentation]. 7th International Myology Congress, Nice, France.
Editorial reviewed

Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (12 September 2022). Relationship between DUX4 and Hypoxia-Inducible Factor (HIF1α) in human and murine muscle cells vitro and in vivo [Poster presentation]. International Myology Congress.
Editorial reviewed

Delpierre, A., Deroux, C., Ris, L., Decleves, A.-E., Legrand, A., Villers, A., & Tassin, A. (12 September 2022). Focus on the endocrine function of skeletal muscle: study of muscle-to-brain communication under voluntary and forced exercise applied in the context of obesity in mice [Poster presentation]. 7th International scientific congress "Myology 2022", Nice, France.
Editorial reviewed

Tchéoubi, E. S. R., Akpovi, C. D., Coppée, F., Tassin, A., Decleves, A.-E., Fiogbé, S. E., Sègbo, G. J., Laurent, S., & Burtea, C. (11 September 2022). PCSK9 variants affect differently the risk of type 2 diabetes mellitus development. Potential impact on the therapy with PCSK9 inhibitors [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis.
Peer reviewed

LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). Towards a muscle-targeted delivery of antisense agents against DUX4 [Poster presentation]. The 29th FSHD Society's annual International Research Congress 2022.
Editorial reviewed

Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Belayew, A., Banerji, R. S. C., Zammit, P., & Tassin, A. (16 June 2022). Relationship between DUX4 and Hypoxia-Inducible Factor (HIF1α) in human and murine muscle cells vitro and in vivo [Poster presentation]. FSHD Society international research congress 2022.
Editorial reviewed

Heher, P., Ganassi, M., Weidinger, A., Engquist, E., Pruller, J., Nguyen, T. H., Tassin, A., Decleves, A.-E., Mamchaoui, K., Banerji, C., Grillari, J., Kozlov, A., & Zammit, P. (16 June 2022). Interplay between mitochondrial reactive oxygen species, oxidative stress, and hypoxic adaptation in FSHD: metabolic stress as a potential therapeutic target [Paper presentation]. FSHD Society international research congress 2022.
Editorial reviewed

Szczepanski, S., LIMPENS, M., Decleves, A.-E., Legrand, A., & Tassin, A. (29 April 2022). Adiponectin pathway in a murine model of disuse muscle atrophy: an in vivo study ? [Poster presentation]. Spring Meeting of the Belgian Society of Physiology and Pharmacology.
Editorial reviewed

Heher, P., Ganassi, M., Weidinger, A., Engquist, E. N., Pruller, J., Nguyen, T. H., Tassin, A., Decleves, A.-E., Mamchaoui, K., Banerji, C. R. S., Grillari, J., Kozlov, A. V., & Zammit, P. S. (25 January 2022). Interplay between mitochondrial reactive oxygen species, oxidative stress and hypoxic adaptation in facioscapulohumeral muscular dystrophy: Metabolic stress as potential therapeutic target. Redox Biology, 51, 102251. doi:10.1016/j.redox.2022.102251
Peer Reviewed verified by ORBi

Decarnoncle, M., Decroo, C., Coppée, F., Tassin, A., Tagliatti, V., Villers, A., Colet, J.-M., Nonclercq, D., Legrand, A., Ris, L., Wattiez, R., & Decleves, A.-E. (25 November 2021). Développement d'une trousse de dosage d'organokines par spectrométrie de masse [Poster presentation]. Networking EpiCURA-UMONS, Baudour, Belgium.

Juszczak, F., Pierre, L., Arnould, T., Tassin, A., & Decleves, A.-E. (2021). AMPK dysregulation in chronic kidney disease: new insights into therapeutic strategies [Paper presentation]. 11th international meeting on AMPK, Evian, France.

Nguyen, T. H., Conotte, S., Belayew, A., Decleves, A.-E., Legrand, A., & Tassin, A. (05 July 2021). Hypoxia and Hypoxia-Inducible Factor Signaling in Muscular Dystrophies: Cause and Consequences. International Journal of Molecular Sciences, 22 (13).
Peer Reviewed verified by ORBi

Nguyen, T. H., Legrand, A., Decleves, A.-E., Heher, P., Banerji, C. R. S., Zammit, P. S., & Tassin, A. (24 June 2021). Exploring the Relationship Between DUX4 and Hypoxia-Inducible Factor (HIF1α) [Poster presentation]. The 28 th FSHD Society's annual International Research Congress 2021.
Editorial reviewed

Delpierre, A., Deroux, C., Ris, L., Decleves, A.-E., Legrand, A., Villers, A., & Tassin, A. (25 May 2021). Muscle-to-Brain communication in the context of obesity: impact of physical exercise? [Paper presentation]. PhysPhar Spring meeting, Belgium.
Editorial reviewed

Juszczak, F., Decarnoncle, M., Tassin, A., & Decleves, A.-E. (14 May 2021). New insights into therapeutic strategies for obesity-induced chronic kidney disease: is there a role for AMPK [Paper presentation]. International Webinar on Nephrology, Urology and Kidney Failure, Webinar (Online Meeting), Unknown/unspecified.

Tassin, A., Szczepanski, S., & Delpierre, A. (2021). Approches translationnelles en réadaptation respiratoire, Conférence FRMH.

Delpierre, A., Akan, M., Deroux, C., Jenart, V., Ris, L., Decleves, A.-E., Legrand, A., Villers, A., & Tassin, A. (30 March 2021). Effect of voluntary and forced exercise on FNDC5-Irisin pathway and muscle-to-brain crosstalk in a model of obesity [Poster presentation]. Mardi des chercheurs, Valenciennes, France.

Juszczak, F., Vlassembrouck, M., Botton, O., Zwakhals, T., Decarnoncle, M., Tassin, A., Caron, N., & Decleves, A.-E. (31 December 2020). Delayed Exercise Training Improves Obesity-Induced ChronicKidney Disease by Activating AMPK Pathway in High-FatDiet-Fed Mice. International Journal of Molecular Sciences, 22 (1). doi:10.3390/ijms22010350
Peer Reviewed verified by ORBi

Tassin, A., & Decleves, A.-E. (2020). AMPK activation : a therapeutic strategy against muscle metabolic alteration in FSHD : Vidéo.

Pierard, M., Tassin, A., Legrand, A., & Legrand, A. (01 October 2020). Chronic hypoxaemia and gender status modulate adiponectin plasmatic level and its multimer proportion in severe COPD patients: new endotypic presentation? BMC Pulmonary Medicine, 20 (255). doi:10.1186/s12890-020-01288-3
Peer reviewed

Derenne, A., Tassin, A., Nguyen, T. H., DeRoeck, E., Jenart, V., Ansseau, E., Belayew, A., Coppée, F., Decleves, A.-E., & Legrand, A. (2020). Induction of a local muscular dystrophy using electroporation in vivo: an easy tool for screening therapeutics. Scientific Reports.
Peer reviewed

Thayse, K., Brogniet, S., Carlier, S., Kindt, N., & Tassin, A. (13 February 2020). Comparison of Vascular Cell Adhesion Molecule-1 (VCAM-1) expression following stimulation with TNF alpha on human umbilical vein endothelial cells and EA.hy926 cells for atherosclerosis research [Paper presentation]. 39th Annual Belgian Society of Cardiology Meeting, Bruxelles, Unknown/unspecified.

Conotte, S., Tassin, A., Delpierre, A., Zouaoui Boudjeltia, K., & Legrand, A. (31 January 2020). Contribution of oxidative stress to muscle dysfunction associated to chronic intermittent hypoxia : an interventional study in a murine model [Poster presentation]. 14th meeting of the FRS-FNRS Contact group on Oxidative Processes and Antioxidants, Mons, Belgium.

Delpierre, A., Villers, A., Deroux, C., Ris, L., Decleves, A.-E., Legrand, A., & Tassin, A. (22 November 2019). Muscle-to-brain communication in the context of obesity : impact of physical exercise [Poster presentation]. Physphar Autumn Meeting, Bruxelles, Unknown/unspecified.
Editorial reviewed

Tassin, A., & Legrand, A. (2019). L'atteinte respiratoire dans la FSHD : - Conférence de vulgarisation scientifique.

Juszczak, F., Vlassembrouck, M., Zwakhals, T., Jenart, V., Botton, O., Gaussin, J.-F., Jadot, I., Tassin, A., Legrand, A., Caron, N., & Decleves, A.-E. (08 September 2019). Role of AMP-activated Protein Kinase in Renal Lipid Accumulation in Obesity-induced Chronic Kidney Disease. Benefits of an Endurance Exercise Training in Mice [Poster presentation]. 4th European Workshop on AMPK, Louvain-la-Neuve, Belgium.

Nguyen, T. H., Tassin, A., Decleves, A.-E., Figeac, N., Heher, P., Banerji, C. R. S., & Zammit, P. S. (20 June 2019). Exploring the Relationship Between DUX4 and Hypoxia-Inducible Factor (HIF1α) [Poster presentation]. FSH Society international research congress, Marseille, France.
Editorial reviewed

Delcourt, M., Delpierre, A., Tassin, A., Colet, J.-M., Decleves, A.-E., & Villers, A. (2019). L'obésité a encore frappé - Le fumarate et son rôle au sein du tissu adipeux.

Nguyen, T. H., Derenne, A., Ansseau, E., De Roeck, E., Coppée, F., Decleves, A.-E., Tassin, A., & Legrand, A. (27 March 2019). Development of easy outcome measures for the in vivo screening of therapeutical agents targeting DUX4 in FSHD [Poster presentation]. MYOLOGY, Bordeaux, France.
Editorial reviewed

Derenne, A., Kouakou, C., Belayew, A., Decleves, A.-E., Tassin, A., Burtea, C., & Coppée, F. (08 March 2019). Development of peptides for specific skeletal muscle targeted drug delivery [Poster presentation]. 2019 Advances in Skeletal Muscle Biology in Health and Disease, University of Florida, United States - Florida.
Editorial reviewed

Delpierre, A., Villers, A., Deroux, C., Ris, L., Decleves, A.-E., Legrand, A., & Tassin, A. (05 March 2019). Inter-communication muscle - cerveau dans un contexte d'obésité : Impact de l'exercice [Poster presentation]. Mardi des Chercheurs 2019 (MdC2019), Mons, Belgium.

Pierard, M., Tassin, A., Conotte, S., Zouaoui, K., & Legrand, A. (2019). Sustained Intermittent Hypoxemia Induces Adiponectin Oligomers Redistribution and a Tissue-Specific Modulation of Adiponectin Receptor in Mice. Frontiers in Physiology.
Peer reviewed

Pierard, M., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (11 December 2018). Effect of hypoxia on adiponectin pathway in murine and cellular models: which involvement in COPD-associated cardiovascular risk ? [Poster presentation]. Europhysiology, London, United Kingdom.
Editorial reviewed

Nguyen, T. H., & Tassin, A. (2018). Etude du crosstalk entre DUX4 et HIF1α dans le cadre de la dystrophie Facio-Scapulo-Humérale (FSHD).

Panamarova, M., Tassin, A., Belayew, A., & Zammit, P. (25 June 2018). Mapping D4Z4 - driven expression profile and dynamics in FSHD [Paper presentation]. New Directions in Biology and Disease of Skeletal Muscle Conference, New Orleans, United States - Louisiana.
Editorial reviewed

Tassin, A., & Legrand, A. (2018). L'importance du muscle au quotidien (A l'occasion de l'événement Carrefour des Générations, en collaboration avec l'ABMM).

Juszczak, F., Vlassembrouck, M., Zwakhals, T., Jenart, V., Botton, O., Gaussin, J.-F., Jadot, I., Tassin, A., Legrand, A., Caron, N., & Decleves, A.-E. (12 April 2018). Role of AMP-Activated Protein Kinase in Renal Lipid Accumulation in Obesity-Induced Chronic Kidney Disease. Benefits of an Endurance Exercise Training in Mice [Paper presentation]. 30th Meeting of the European Renal Cell Study Group, Florence, Italy.

Juszczak, F., Vlassembrouck, M., Tassin, A., Legrand, A., Caron, N., & Decleves, A.-E. (27 March 2018). Study of Renal Lipid Accumulation in Obesity-induced Chronic Kidney Disease in Mice. Benefits of an Endurance Exercise Training [Poster presentation]. Mardi des Chercheurs (MdC2018), Valenciennes, France.

Conotte, S., Tassin, A., Conotte, R., Colet, J.-M., Zouaoui, K., & Legrand, A. (27 February 2018). Metabonomic profiling of chronic intermittent hypoxia in a mouse model. Respiratory Physiology and Neurobiology, 256, 157_173. doi:10.1016/j.resp.2018.02.015
Peer Reviewed verified by ORBi

Vanderplanck, C., Tassin, A., Ansseau, E., Charron, S., Wauters, A., Lancelot, C., Vancutsem, K., Laoudj Chevinesse, D., Belayew, A., & Coppée, F. (12 January 2018). 'Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei'. Skeletal Muscle, 8 (2). doi:10.1186/s13395-017-0148-4
Peer reviewed

Pierard, M., Conotte, S., Tassin, A., Zouaouia-Boudjeltia, K., & Legrand, A. (2017). Effect of hypoxia on adiponectin pathway in murine and cellular models: which involvement in COPD-associated cardiovascular risk? [Paper presentation]. Federation of European Physiological Societies (FEPS), Viennes, Austria.

Derenne, A., Tassin, A., Burtea, C., Decleves, A.-E., & Coppée, F. (13 September 2017). Development of specific molecules using the phage display technology allowing a targeted drug delivery to skeletal muscles in the aim to treat muscular disorders.» [Paper presentation]. Journée PhD day EDT en Sciences Pharmaceutiques, Liège, Belgium.
Editorial reviewed

Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Decleves, A.-E., & Legrand, A. (11 May 2017). DUX4 surexpression and silencing in a murine model [Poster presentation]. Interuniversity PhD student, Liège, Belgium.

Panamarova, M., Tassin, A., Moyle, L., Belayew, A., & Zammit, P. (2017). Generation of a mouse model of FSHD to reveal the DUX4 expression profile and dynamics [Paper presentation]. 10th Neuromuscular Translational Research Conference, London, United Kingdom.

Derenne, A., De Roeck, E., Tassin, A., Coppée, F., Belayew, A., Decleves, A.-E., & Legrand, A. (07 March 2017). DUX4 surexpression and silencing in a murine model [Poster presentation]. Mardi des Chercheurs (MdC2017), Mons, Belgium.

Pierard, M., Tassin, A., Legrand, A., & Legrand, A. (07 March 2017). Adiponectin modulation in different COPD endotypes: a preliminary clinical study [Poster presentation]. Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium.

Pierard, M., Conotte, S., Tassin, A., Boutry, S., Uzureau, P., Zouaoui Boudjeltia, K., & Legrand, A. (2016). Interactions of exercise training and high-fat diet on adiponectin forms and muscle receptors in mice. Nutrition and Metabolism. doi:10.1186/s12986-016-0138-2
Peer Reviewed verified by ORBi

Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (30 June 2016). Modulations of adiponectin pathway inuced by hypoxia in murine and cellular models [Poster presentation]. Federation of European Physiological Societies, Paris, France.
Editorial reviewed

Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Paper presentation]. Federation of European Physiological Societies, Paris, France.

Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (2016). Modulations of adiponectin pathway induced by hypoxia in murin and cellular models [Paper presentation]. Federation of European Physiological Societies, Paris, France.

Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (28 June 2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Poster presentation]. Federation of European Physiological Societies, Paris, France.

Pierard, M., Delpierre, A., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (18 May 2016). Composante hypoxémique de la BPCO : quel impact sur les ADIPO-récepteurs ? [Poster presentation]. MDC 2016 Valenciennes, Valenciennes, France.

Conotte, S., Tassin, A., Nuyens, V., Zouaoui Boudjeltia, K., & Legrand, A. (22 April 2016). effect of chronic intermittent hypoxia on muscle function in a mouse model of obstructive sleep apnea [Poster presentation]. 12th meeting of the FRS-FNRS Contact Group on oxidative stress and antioxydants : New Frontiers in Oxidative Stress and Redox Regulation, Louvain-la-Neuve, Belgium.

Ansseau, E., O, J., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj Chevinesse, D., Wattiez, R., Harper, S., Belayew, A., & Coppée, F. (14 March 2016). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Poster presentation]. International Congress Of Myology, Lyon, France.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (14 March 2016). 'Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy.' [Poster presentation]. 5th International Congress of Myology, Lyon, France.

Ansseau, E., Eidal, J., Lancelot, C., Tassin, A., Matteotti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (2016). Homologous transcription factors DUX4 and DUX4c associate with cytoplasmic proteins during muscle differentiation. PLoS ONE.
Peer reviewed

Panamarova, M., Tassin, A., Moyle, L., Belayew, A., & Zammit, P. (05 January 2016). Generation of a mouse model of FSHD to reveal the DUX4 expression profile and dynamics [Paper presentation]. UK Neuromuscular Translational Research Conference, Oxford, United Kingdom.
Editorial reviewed

Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (06 November 2015). Cardiovascular alterations associated to intermittent hypoxia in a mouse model of obstructive sleep apnea (OSA) [Poster presentation]. autumn meeting Belgian Society of Physiology and Pharmacology, Bruxelles, Belgium.

Pierard, M., Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (06 November 2015). Effect of continuous and intermittent hypoxia on adiponectin multimeric forms and muscle receptors in mice [Poster presentation]. autumn meeting Belgian Society of Physiology and Pharmacology, Bruxelles, Belgium.

Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (06 October 2015). The translocation of DUX4 and DUX4c during myoblast differentiation allows their association with nucleo-cytoplasmic proteins associated with mRNP granules [Paper presentation]. FSH society, Boston, United States - Massachusetts.

Ansseau, E., Eidahl, J. O., Lancelot, C., Tassin, A., Matteoti, C., Yip, C., Liu, J., Leroy, B., Hubeau, C., Gerbaux, C., Cloet, S., Wauters, A., Zorbo, S., Meyer, P., Pirson, I., Laoudj-Chenivesse, D., Wattiez, R., Harper, S. Q., Belayew, A., & Coppée, F. (04 October 2015). Unexpected location of DUX4/4c transcription factors in the cytoplasm suggests a role in mRNP granules and translation regulation [Poster presentation]. International World Muscle Society Congress, Brighton, United Kingdom.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Paper presentation]. International World Muscle Society congress, Brighton, United Kingdom.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., & Belayew, A. (21 September 2015). Caveolar proteins : putative FSHD biomarkers [Poster presentation]. EMBO workshop : Molecular Mechanisms of muscle growth and wasting in health and disease, Ascona , Unknown/unspecified.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (22 May 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. Journée UMHAP from lab to bedside, Mons, Belgium.

Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (12 May 2015). Effet de l'exercice physique sur l'adiponectine dans un modèle murin de syndrome métabolique [Poster presentation]. Journée scientifique du Pôle hainuyer (JSPH1), Mons, Belgium.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (17 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of facioscapulohumeral muscular dystrophy (FSHD [Poster presentation]. Novel Therapies for monogennic diseases, Paris, France.

Vanderplanck, C., Tassin, A., Ansseau, E., Lancelot, C., Derenne, A., Conotte, S., Dudome, V., Leroy, B., Wilton D., S., Laoudj-Chenivesse, D., Wattiez, R., Legrand, A., Belayew, A., & Coppée, F. (15 April 2015). Antisense strategies targeting DUX4 and DUX4c for the treatment of Facioscapulohumeral muscular dystrophy [Poster presentation]. symposium de thérapie génique du Collège de France, Paris, France.

Conotte, S., Tassin, A., & Legrand, A. (2015). Des traces dans nos artères.

Conotte, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (10 March 2015). Pathophysiological effects of a well-controlled exposure to intermittent hypoxia in mice : validation of a sleep apnea model [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (10 March 2015). Membrane proteins : putative FSHD biomarkers [Poster presentation]. 8ème édition de la Matinée de Chercheurs, Mons, Belgium.

Pahulycz, L., Tassin, A., Conotte, S., Zouaoui Boudjeltia, K., Piagnerelli, M., & Legrand, A. (10 March 2015). Impact of hyperoxia in a murine model of intensive care unit myopathy [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.

Pahulycz, L., Piagnerelli, M., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (23 January 2015). Impact de l'hyperoxie sur la myopathie dans un modèle murin de sepsis [Poster presentation]. 43e Congrès International de la SRLF (Société de Réanimation de Langue Française), Paris, France.

Robbe, A., Tassin, A., Carpentier, J., Decleves, A.-E., Mekinda Ngono, Z. L., Nonclercq, D., & Legrand, A. (09 January 2015). Intratracheal bleomycin aerosolization: the best route of administration for a scalable and homogeneous pulmonary fibrosis rat model? BioMed Research International, 2015 (198418), 1-9. doi:10.1155/2015/198418
Peer Reviewed verified by ORBi

Lancelot, C., Tassin, A., Legrand, A., & Belayew, A. (2014). Interview radio et article internet - Le téléthon soutient aussi les chercheurs belges -.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (19 October 2014). Membrane proteins: putative FSHD biomarkers? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California.

Ansseau, E., Matteoti, C., Tassin, A., Lancelot, C., Leroy, B., Hubeau, C., Nachtegael, C., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Meyer, P., Carnac, G., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (17 October 2014). Unexpected role for DUX transcription factors into the cytoplasm [Paper presentation]. International Research Consortium & Research Planning Meetings, San Diego, United States - California.

Derenne, A., Tassin, A., Conotte, S., Coppée, F., Belayew, A., & Legrand, A. (17 October 2014). Comparison of two methods of naked DNA delivery in mice: which one is the most appropriate in the FSHD context? [Poster presentation]. FSH Society international research consortium and research planning meeting, San Diego, United States - California.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Coppée, F., Wattiez, R., & Belayew, A. (08 July 2014). Membrane proteins : putative FSHD biomarkers? [Poster presentation]. ICNMD 13th International Congress in NeuroMuscular Diseases, Nice, France.

Lancelot, C., Ansseau, E., Tassin, A., Matteoti, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (06 July 2014). Study of the double homeodomain DUX protein partners: focus on the interaction with desmin [Paper presentation]. IF-NMD Workshop Nice 2014 - Satellite Workshop to ICNMD, Nice, France.

Tassin, A., Ansseau, E., Matteotti, C., Lancelot, C., Leroy, B., Gerbaux, C., Zorbo, S., Cloet, S., Yip, C., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (14 May 2014). Study of the double homeodomain DUX protein partners highlights DUX4c involvement in human muscle regeneration [Paper presentation]. EMBO Conference : Molecular Biology of Muscle Development and Regeneration, Acaya-Lecce, Italy.
Editorial reviewed

Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (05 April 2014). Effect of exercise training on adiponectin multimeric forms in a mouse model of metabolic syndrome [Paper presentation]. PhysPhar Meeting, Maastricht, Netherlands.
Editorial reviewed

Conotte, S., Tassin, A., & Legrand, A. (04 April 2014). Metabonomic profiling of intermittent hypoxia in a mouse model [Poster presentation]. PhysPhar Meeting, Maastricht, Netherlands.

Pierard, M., Conotte, S., Boutry, S., Tassin, A., Zouaoui Boudjeltia, K., & Legrand, A. (04 April 2014). Effect of exercise training on adiponectin multimeric forms in a mouse model of metabolic syndrome [Poster presentation]. PhysPhar Meeting, Maastricht, Netherlands.

Vanderplanck, C., Tassin, A., Lancelot, C., Ansseau, E., Nonclercq, D., Delrée, P., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (27 November 2013). DUX4c, a DUX4-homologue, causes the FSHD disorganized myotube phenotype: an additional target for therapeutic strategies [Paper presentation]. Colloque Myogenèse XVI, Montpellier, France.

Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (24 May 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium.

Tassin, A., Vanderplanck, C., Ansseau, E., Derenne, A., Coppée, F., & Belayew, A. (24 May 2013). Different approaches to evaluate antisense strategies against the causal gene of the FSHD myopathy [Poster presentation]. Journée de l'Institut de recherche en sciences et technologies de la santé, Mons, Belgium.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (24 May 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. 1st Health Institute Day, Mons, Belgium.

Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (22 April 2013). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. MDA Scientific Conference, Washington DC, United States - District of Columbia.

Wauters, A., Tassin, A., Leroy, B., Laval, S., Wattiez, R., Coppée, F., & Belayew, A. (29 January 2013). Caveolar proteins: putative FSHD biomarkers? [Poster presentation]. ', Journée de l'école doctorale en sciences biomédicales et pharmaceutiques, UMONS, Mons, Belgium.

Tassin, A., Laoudj-Chenivesse, D., Vanderplanck, C., Barro, M., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (01 January 2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? Journal of Cellular Molecular Medecine, 17 (1), 1-15. doi:10.1111/j.1582-4934.2012.01647.x
Peer reviewed

Tassin, A., Leroy, B., Laoudj-Chenivesse, D., Wauters, A., Vanderplanck, C., Le Bihan, M.-C., Coppée, F., Wattiez, R., & Belayew, A. (18 December 2012). FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes. PLoS ONE, 7 (12), 51865. doi:10.1371/journal.pone.0051865
Peer reviewed

Tassin, A., Vanderplanck, C., Leroy, B., Charron, S., Ansseau, E., Wauters, A., Laoudj-Chenivesse, D., Wattiez, R., Belayew, A., & Coppée, F. (07 November 2012). Investigations on the FSHD disorganized myotube phenotype [Poster presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States.

Ansseau, E., Vanderplanck, C., Wallace, L. M., Tassin, A., Domire, J. S., Guckes, S. M., Yip, C., Laoudj-Chenivesse, D., Coppée, F., Wilton D., S., Harper, S. Q., & Belayew, A. (06 November 2012). Evaluation of new antisense oligomers targeting the DUX4 mRNA as a therapeutic strategy for FSHD [Paper presentation]. FSH Society International Reasearch Consortium Meeting, San Francisco, United States.

Tassin, A., Laoudj-Chenivesse, D., Charron, S., Ansseau, E., Chen, Y.-W., Mercier, J., Coppée, F., & Belayew, A. (07 November 2011). Detection of endogenous DUX4 protein in FSHD muscles: could the spreading of a rare protein cause FSHD? [Poster presentation]. FSH Society International Research Consortium & Reasearch Planning Meeting, Boston, United States - Massachusetts.

Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (01 November 2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression and corrected by its suppression. PLoS ONE, 6 (10), 26820. doi:10.1371/journal.pone.0026820
Peer reviewed

Tassin, A. (29 June 2011). Study of a deregulation cascade in FSHD primary myotubes by differential mass spectrometry [Paper presentation]. 7th Meeting of the London Myology Forum, Londres, United Kingdom.
Editorial reviewed

Tassin, A. (2011). Oral presentation for the MDC (Muscular Dystrophy Campaign).

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (12 May 2011). Interfering with the transcription deregulation cascades in fshd [Paper presentation]. 4th international congress of myology 2011, Lille , France.

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Vanderplanck, C., Wauters, A., Turky, D., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (12 May 2011). The galectin-1 gene is activated in FSHD Myotubes as a result of the DUX4 transcriptional deregulation cascade [Poster presentation]. 4th international congress of myology 2011, Lille , France.

Vanderplanck, C., Ansseau, E., Charron, S., Tassin, A., Turki, A., Laoudj-Chenivesse, D., Wilton D., S., Coppée, F., & Belayew, A. (06 May 2011). SUPPRESSION OF DUX4 OR DUX4C EXPRESSION BY ANTISENSE STRATEGIES IN A THERAPEUTIC APPROACH FOR FSHD [Paper presentation]. 7th AGTS Meeting, Melbourne, Australia.

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Charron, S., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (14 March 2011). Suppression of DUX4 or DUX4c protein expression by antisense strategies in a therapeutic approach for FSHD [Paper presentation]. MDA national scientific conference Neuromuscular Therapeutic Strategies: Overcoming the Barriers from Microscope to Marketplace, Las Vegas, United States - Nevada.

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Faille, J., Leclercq, T., Charron, S., Laoudj-Chenivesse, D., Coppée, F., Wattiez, R., & Belayew, A. (25 November 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. VIIIè journées annuelles Société Française de Myologie, Nice, France.

Tassin, A., Leroy, B., Ansseau, E., Pire, E., Charron, S., Coppée, F., Wattiez, R., & Belayew, A. (25 October 2010). Focus on nuclear proteins of FSHD primary myotubes by differential mass spectrometry [Poster presentation]. FSHD International Research Consortium Meeting, Boston, United States - Massachusetts.

Vanderplanck, C., Coppée, F., Ansseau, E., Tassin, A., Laoudj-Chenivesse, D., Wilton D., S., & Belayew, A. (21 October 2010). Suppression of DUX4 or DUX4c protein expression by antisense strategies as a therapeutic approach for FSHD [Paper presentation]. FSH Society International Research Consortium & Research Planning Meeting, Boston, United States - Massachusetts.

Charron, S., & Tassin, A. (27 February 2010). Contribution à l'étude de la FSHD [Paper presentation]. Troisième journée sur les Maladies Rares, Radiorg, Bruxelles, Belgium.

Tassin, A., Coppée, F., Leroy, B., Sauvage, S., Preillon, J., Erculisse, V., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (09 November 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. FSH Society International Research Consortium and Research Planning Meetings, Boston, United States - Massachusetts.
Editorial reviewed

Tassin, A., Charron, S., Vanderplanck, C., Coppée, F., & Belayew, A. (2009). Des techniques en 'omique' pour comprendre une maladie héréditaire des muscles.

Tassin, A., & Belayew, A. (31 October 2009). Etude des protéines DUX4, DUX4c, PITX1 et de leur rôle dans le mécanisme moléculaire de la FSHD [Paper presentation]. Assemblée Générale des Amis FSH Europe, Agde, France.

Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Tassin, A., Vanderplanck, C., Sauvage, S., Barro, M., Mahieu, I., Leroy, A., Leclercq, I., Mainfroid, V., Figlewicz, D., Mouly, V., Butler-Browne, G., Belayew, A., & Coppée, F. (01 October 2009). DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation. PLoS ONE, 4 (10), 7482. doi:10.1371/journal.pone.0007482
Peer reviewed

Tassin, A., Coppée, F., Leroy, B., Erculisse, V., Sauvage, S., Charron, S., Vanderplanck, C., Barro, M., Vander Elst, L., Muller, R., Laoudj-Chenivesse, D., Colet, J.-M., Wattiez, R., & Belayew, A. (27 July 2009). Investigations on the molecular mechanism of a muscular dystrophy (FSHD) by proteomic and metabonomic analyses of primary myoblast cultures [Paper presentation]. International Symposium Signal transduction and disease, Aachen, Germany.
Editorial reviewed

Tassin, A. (12 June 2009). Etude de la surexpression de DUX4, DUX4c et PITX1 et du protéome nucléaire des myotubes FSHD [Paper presentation]. Colloque 'jeunes chercheurs' de l'AFM (Association Française contre les Myopathies).
Editorial reviewed

Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T., Garner, H. R., Agha-Mohammadi, S., Tassin, A., Coppée, F., Belayew, A., Perlingeiro, R., & Kyba, M. (01 October 2008). An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO Journal, 27 (20), 2766-79.
Peer Reviewed verified by ORBi

Tassin, A., Vanderplanck, C., Ansseau, E., Marcowyzc, A., Barro, M., Laoudj-Chenivesse, D., Belayew, A., & Coppée, F. (26 May 2008). Studies on the expression and function of DUX4c, a gene located close to the FSHD locus [Poster presentation]. 3ème Congrès International de Myologie, Marseille, France.

Tassin, A., Ansseau, E., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (21 January 2008). DUX4 and DUX4c activate different pathways in Facioscapulohumeral dystrophy [Paper presentation]. Colloque « Myogenese IX », Institut de Myologie, Paris, France.
Editorial reviewed

Tassin, A., Vanderplanck, C., Ansseau, E., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Dabauvalle, M. C., Wehnert, M., Chen, Y.-W., Belayew, A., & Coppée, F. (2008). Study of DUX4 and DUX4c in facioscapulohumeral muscular dystrophy [Paper presentation]. 13th International WMS Congress, Newcastle upon Tyne, United Kingdom.

Ansseau, E., Tassin, A., Vanderplanck, C., Cloet, S., Barro, M., Laoudj-Chenivesse, D., Chen, Y.-W., Belayew, A., & Coppée, F. (04 November 2007). Further studies on the DUX4, DUX4c and PITX1 genes in FSHD [Paper presentation]. FSHD international Workshop meeting, San Diego, United States - California.

Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Mattéotti, C., van Acker, A., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppée, F., & Chen, Y.-W. (01 November 2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104 (46), 18157-18162. doi:10.1073/pnas.0708659104
Peer Reviewed verified by ORBi

Tassin, A., Ansseau, E., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Laoudj-Chenivesse, D., Oberdan, L., Coppée, F., & Belayew, A. (18 December 2006). Evidence for the expression of the DUX4 gene in primary myoblasts of patients affected with Facioscapulohumeral muscular dystrophy [Poster presentation]. 194th Congrès de la Société Belge de Biochimie et de Biologie Moléculaire / 'Young Scientists Day, Gembloux, Belgium.

Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Sauvage, S., Barro, M., Tassin, A., Mattéotti, C., van Acker, A., Leroy, A., Leclercq, I., Leo, O., Figlewicz, D., Belayew, A., & Coppée, F. (2006). Characterization of the DUX4c gene located within a repeated element close to the FSHD locus [Paper presentation]. 11th International Congress of the World Muscle Society, Bruges, Belgium.

Ansseau, E., Tassin, A., Sauvage, S., Laoudj-Chenivesse, D., Barro, M., Figlewicz, D., Coppée, F., & Belayew, A. (09 October 2006). DUX4 gene expression in FSHD primary myoblasts [Paper presentation]. FSHD International Consortium Research Meeting, New Orleans, United States - Louisiana.

Marcowycz, A., Mahieu, I., Tassin, A., Coppée, F., & Belayew, A. (17 May 2006). The DUX4 and DUX4c proteins, encoded by candidate genes for a muscular dystrophy (FSHD), have opposite functions in vivo [Poster presentation]. Bioforum, Liège, Belgium.

Ansseau, E., Laoudj-Chenivesse, D., Marcowycz, A., Barro, M., Sauvage, S., Mattéotti, C., Mahieu, I., Tassin, A., Van Acker, A.-M., Leo, O., Fliglewicz, D., Coppée, F., & Belayew, A. (13 January 2006). Etude de DUX4 et DUX4c, gènes candidats pour la FSHD [Paper presentation]. Club muscle 'V', Paris, France.

Laoudj-Chenivesse, D., Barro, M., Sauvage, S., Tassin, A., Ansseau, E., Marcowycz, A., Figlewicz, D., Van Acker, A.-M., Leo, O., Belayew, A., & Coppée, F. (25 October 2005). Overexpression of the double homeodomain protein DUX4c in FSHD muscle [Paper presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah.

Tassin, A., Sauvage, S., Mattéotti, C., Van Acker, A.-M., Figlewicz, D., Padberg, G. W., Oberdan, L., Coppée, F., & Belayew, A. (25 October 2005). Studies on the expression of the DUX4 and DUX4c proteins [Poster presentation]. FSHD International Consortium Research Meeting, Salt Lake City, United States - Utah.

Belayew, A., Ansseau, E., Sauvage, S., Marcowycz, A., Laoudj-Chenivesse, D., Carnac, G., Mattéotti, C., Gerbaux, C., Mahieu, I., Zorbo, S., Leclercq, I., Tassin, A., Figlewicz, D., & Coppée, F. (09 June 2005). Etude fonctionnelle de DUX4 et DUX4c, et de leur rôle dans la dystrophie de Landouzy-Dejerine [Paper presentation]. Meeting « Club Muscle IV », Marseille, France.

Caron, N., Tassin, A., Devuyst, O., & Legrand, A. (29 November 2004). Effects of sodium nitroprusside and L-arginine on renal vascular resistance in rats with chronic renal failure [Paper presentation]. 37th Annual Meeting of the American Society of Nephrology, St Louis, United States.

Contact ORBi UMONS